(PMTCT)
| The growing complexity of managing children with established HIV infection is well-suited to a virtual exchange of information. Clinical trials data for children continue to lag behind adults and are often limited in scope. Many clinicians make treatment choices based upon preliminary data from adult trials. Others choose to offer patients regimens that have never been studied. The majority of children in care at centers throughout the United States have had many years of drug therapy and often require untested treatment regimens. Little, if any data, may be available to support these treatment decisions. This website provides clinicians the opportunity to ask others to share their management experience and their advice, transforming one’s individual experience into a more generalized collective experience. Treatment issues for HIV-infected pregnant women are similarly complex and clinicians caring for these women are also offered the opportunity to exchange information. Treatment decisions during pregnancy have broad long-term implications for both the mother and the child. The opportunity to exchange information with other clinicians can supplement valuable knowledge gained from published guidelines and clinical trials data. The website invites providers who care for large numbers of HIV-infected women to share their experiences. For those with limited patient numbers, it offers a place to ask questions and learn from the work of others. The website offers a forum for HIV providers in countries with limited access to diagnostics and therapeutic interventions to exchange ideas and to interact with colleagues who have had the opportunity and luxury to use a wide variety of treatments. For those who are beginning to experience increased access to treatments, there is much to be gained from both the errors and triumphs of the past decade of therapy. HIVfiles.org also affords users the opportunity to begin a dialogue with colleagues throughout the world about a wide variety of issues affecting care of HIV-infected children and their families.More useful info at fractology.org In addition to case discussions, the site will provide
a forum for discussion of “hot topics” and emerging issues.
Each month an invited guest will host a discussion on a topic of interest.
Website participants are invited to take the debates which generally
occur in the hallways outside meeting rooms into the message board and
express on-line opinions. In the coming months, we anticipate hosting
discussions on a number of topics including: |
|
II. PROGRESS TOWARDS TARGET INDICATORS FOR
PMTCT PROGRAM
During the last quarter 34 new sites started PMTCT services with support of the Foundation, making a total of 100 sites providing a package of PMTCT services which includes but is not limited to pre- and post-test counseling for HIV to all pregnant clients, rapid HIV testing, provision of Nevirapine for all HIV infected mothers and their exposed infants, modified safe obstetric practices, counseling on exclusive breast feeding, nutritional feeding for the mother and family planning. Of those 100 sites, 33 are run by Faith Based Organizations (FBOs). For all sites supported by the Elizabeth Glaser Pediatric AIDS Foundation see attachment I. The PMTCT services are fully integrated in the MCH and labor and delivery services and are supporting an essential package of prenatal care, which includes at a minimum the following components: 1) focused visits, 2) birth preparedness, 3) disease detection, including Hb, syphilis and other testing, 4) prevention and treatment of diseases, including intermittent presumptive treatment of malaria with SP, and 5) counseling on nutrition, including providing supplementation of micronutrients. Supplies of Nevirapine, Capillus and Determine In January the programs were ready to start but unfortunately the Nevirapine and Determine through the donation program was not yet cleared through customs. Fortunately, Axios/Tanzania shared commodities for the start up the services, and after a few weeks the commodities were returned. Stocks of Determine and Nevirapine are sufficient to last at least 6 more months. The supplies were distributed by EMS during a meeting in Arusha. The memorandum of understanding with MSD was finalized and signed. Capillus was bought from MSD and the sites were able to pick up the test kits at the zonal stores. Unfortunately this did not go very smoothly, and a lot of follow up was necessary. None of the sites were without test kits or NVP. Compliance training for EGPAF personnel and sub grantees In February 2005, the Technical Director, the PMTCT Program Officer and the Compliance Assistant and 1-2 representatives from each sub grantee attended a USAID Rules and Regulation workshop in Arusha presented by the Association of Private Volunteer Organization Financial Managers (APVOFM). For each sub grant, the program manager and financial manager/accountant was invited. The training was useful and gave a better understanding of compliance issues, especially for sub grantees new to USG funding. |
Dispensing of NVP to mothers and infantsThe dispensing of NVP to HIV infected mothers and their infants is still a challenge. At this moment all sites provide, according to the national PMTCT guidelines, NVP at 28 weeks of pregnancy or later at the ANC clinic. Mothers are instructed to swallow the tablet by the onset of labor. This is to accommodate women who, for different reasons do not deliver at the facility. NVP is also provided at the labor ward. However, we still do not reach all the mothers, because some do not return after 28 weeks and do not deliver in a health facility and we do not know how many of the mothers who received NVP during ANC actually swallow the tablet at home. For infants there is still no proper dispensing mechanism at this moment. The NVP donation was packaged together with special syringes in which NVP can be dispensed to take home and administer in the event of a home birth. However, this is not according to the national PMTCT guidelines and therefore will need further discussion with the PMTCT Secretariat. According to the manufacturer, NVP is stable for 2 months in a normal syringe and 6 months in a special syringe. Follow up of mothers and infants We also discussed whether new PMTCT sites can start recording HIV infected mothers once they are diagnosed and develop a mechanism for follow up of them and their infants. Depending on the site this could be through TBAs, Community Health Workers, Home Based Care workers or facility based staff. |